<DOC>
	<DOCNO>NCT02828397</DOCNO>
	<brief_summary>Primary Objective : Determine blood concentration two formulation REGN2222 Secondary Objective : Assess safety tolerability REGN2222</brief_summary>
	<brief_title>Study Blood Concentrations Two Formulations REGN2222 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Key 1 . Healthy man woman age 18 60 year 2 . Body weight 50.0 kg 95.0 kg , inclusive 3 . Willing able comply clinic visit studyrelated procedure 4 . Provide sign informed consent Key 1 . Hemoglobin within normal limit 2 . Positive drug alcohol screen test result screen visit 1 2 3 . Participation clinical research study evaluate another investigational drug therapy within 30 day least 5 halflives , whichever longer , investigational drug , prior screen visit 4 . Pregnant breastfeed woman , woman childbearing potential 5 . Sexually active men unwilling practice adequate contraception study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>